Clinical Trial Update: A Phase II Open-label Single-arm Study to Evaluate the Efficacy and Safety of ADSCs in Subjects With Liver Cirrhosis [Phase 2]

View source ↗

Summary

Phase II open-label single-arm study assessing adipose-derived stem cells (ADSCs) for efficacy and safety in liver cirrhosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis

Drugs mentioned

• ADSCs (adipose-derived stem cells)

Snippet

Sponsor: Gwo Xi Stem Cell Applied Technology Co., Ltd. | Conditions: Liver Cirrhosis | Phase 2 | Status: UNKNOWN